Acutaas Chemicals Ltd · NSE:ACUTAAS
Acutaas Chemicals — Ami Organics — Q3 FY2025 Earnings Presentation
41 slides from Acutaas Chemicals's earnings presentation, Jan 28, 2025
Slide 1: Exchange filing cover letter
Afi Ami Organics Limited CIN. : L24100GJ2007PLCO51093 Registered Office :- Plot No. 440/4, 5 & 6, Road No. 82/A, G.L.D.C. Sachin, Surat - 394230, Dist. Surat, Gujarat, India. January 28, 2025 To, To, The Listing Department, The Listing Department BSE LIMITED, National Stock Exchange of India Limited,
Slide 2: Investor Presentation
Investor Presentation JANUARY 2025 AMI ORGANICS LTD. BSE : 543349 | NSE : AMIORG | www.amiorganics.com i i | ecovadis § (R sustainebility Rating "“ L. APR2024 ¥
Slide 3: Table of Contents
Ao AMI ORGANICS LTD. Table of Contents Q3 & IMFY25 Results Company Overview Advanced Pharma Intermediate Specialty Chemicals Working towards better tomorrow
Slide 4: 1. Q3 & 9MFY25 Results
Ao AMI ORGANICS LTD. 1. Q3 & 9MFY25 Results Management Commentary VY Q3FY25 Earnings Highlights V Q3FY25 Business Highlights V Q3FY25 Financial Performance — Key Metrics V 9MFY25 Financial Performance — Key Metrics V Q3 & 9MFY25 Financial Performance — P&L Statement V Financial Performance over the
Slide 5: Management Commentary
AMI ORGANICS LTD. Management Commentary "l am delighted to share that in the first nine months of FY25, we achieved revenue of 698 crore, nearly equaling the revenue from operations of the entire previous financial year. In Q3FY25 alone, we delivered an impressive 65.2% year-on-year growth, achievin
Slide 6: Q3FY25 Earnings & Business Highlights
Ao AMI ORGANICS LTD. Q3FY25 Earnings & Business Highlights > Revenue from operations for Q3FY25 grew by 65.2% YoY to Rs. 2,750 mn > The gross margin for the quarter improved to 46.2% up 333 bps YoY and 281 bps QoQ > EBITDA for the quarter came at Rs. 687 mn up 159.0% YoY compared to Rs. 265 mn in Q3
Slide 7: Q3FY25 Financial Performance - Key Metrics
Q3FY25 Financial Performance - Key Metrics Afl AMI ORGANICS LTD. Revenue from Operations (Rs Mn) YoY Growth 85.7% 2,389 = Q3FY24 mQ3FY25 2,750 1,664 1,286 378 361 Advance Intermediates Specialty Chemicals Total EBITDA & EBITDA Margin (Rs Mn) 25.0% Q3FY24 Q3FY25 Q3FY24 Q3FY25 — EBITDA =O—EBITDA Margin
Slide 8: 9MFY25 Financial Performance — Key Metrics
9MFY25 Financial Performance — Key Metrics Afl AMI ORGANICS LTD. Revenue from Operations (Rs Mn) YoY Growth @ " IMFY24 ®IMFY25 6,984 5,809 4,925 3,782 - , 1 -_— Ni i 1 = Advance Intermediates Specialty Chemicals Total EBITDA & EBITDA Margin PAT (Rs Mn) (Rs Mn) 21.1% 17.3% o— IMFY24 IMFY25 9MFY24 IMFY
Slide 9: Q3 & 9MFY25 Financial Performance - P&L Statement
Q3 & 9MFY25 Financial Performance - P&L Statement AMI ORGANICS LTD. Particulars (Rs. Mn) Q3FY25 Q3FY24 YoY Q2FY25 9MFY25 9MFY24 COGS 1478 950 1,396 3,897 2,767 Gross Margin 46.2% 42.9% 43.4% 44.2% 43.8% Employee benefits expenses 217 161 196 604 461 Other expenses 368 288 386 1012 844 Total Expenses
Slide 10: Financial Performance over the years — Key Metrics
Financial Performance over the years — Key Metrics Afl AMI ORGANICS LTD. Revenue from Operations- Growth Trends (R Mn) FY20 ®Fy21 WFY22 ®FY23 WFY24 BIMFY25 FY20-24 CAGR: 775 6,984 5809 6,170 5678 5,180 Advance Intermediates Chemicals Total Revenue - by Business Verticals Revenue from exports (Rs Mn)
Slide 11: Financial Performance over the years — Key Metrics (cont'd)
Financial Performance over the years — Key Metrics (cont'd) AMI ORGANICS LTD. EBITDA and EBITDA Margins (%) PAT and PAT Margins (%) 23.5% 21.1% 15.9% 13.8% 11.5% I | FY20 Fy21 Fy22 Fy23 Fy24 IMFY25 FY20 FY21 FY22 FY23 FY24 9M FY25 " EBITDA R Mn) =O=EBITDA Margin (%) W PAT (R Mn) =0=PAT Margin (%) Lo
Slide 12: Financial Performance over the years - Profit and Loss
Financial Performance over the years - Profit and Loss Afl AMI ORGANICS LTD. Particulars (INR mn) FY21 FY22 FY23 FY24 9M FY25 Revenue from Operations 3,406 5,201 6,167 7175 6,984 Other Income 14 28 43 75 112 Total Income 3,420 5,229 6,210 7,250 7,095 Cost of materials consumed 1,749 2,823 3,459 4,402
Slide 13: Financial Performance over the years - Balance Sheet
Financial Performance over the years - Balance Sheet Ao AMI ORGANICS LTD. Assets (INR mn) FY22 FY23 FY24 H1FY25 f:';lty and Liabilities (INR FY22 FY23 FY24 H1FY25 Property, plant and 1422 1584 1,844 3229 3,171 N equipment Shareholder’s equity 1,669 5,223 5,939 6,828 12,118 Right of use assets 184 19
Slide 14: Shareholder Information
Shareholder Information AMI ORGANICS LTD. Shareholding as on 31st December 2024 Share Information as on 315t December 2024 NSE Ticker AMIORG BSE Ticker 543349 Others Promoters 28.3% 36.0% Market Cap (Rs. Cr) 8,796 Shares Outstanding 4,09,34,461 3M ADTV (Shares)* 2,81,751 3M ADTV (Rs. cn)* 55.41 Fll
Slide 15: 2. Company Overview
AMI ORGANICS LTD. 2. Company Overview Company Overview VYV V Our Journey Our Products V Strong and Long-term relations with Diversified Customers Y across Geographies Our Manufacturing Facilities V V Superior R&D Capabilities V.V Our Founders Our Leadership What makes us different Y
Slide 16: Ami Organics — At a Glance
Ami Organics — At a Glance AMI ORGANICS LTD. Business Segments » One of the leading Research and Development driven manufacturer of Specialty Chemicals oo@? 20\ » Focused on the development and manufacturing of: ? * Advanced Pharmaceutical Intermediates . . Advanced Pharmaceutical Specialty ‘ Speaal
Slide 17: The Evolution
The Evolution 0 AMI ORGANICS LTD. > 2004 2005 2006 2011 Formation of partnership firm in the name of Guijarat Gas Safety Award — developing and Change in constitution from partnership firm to Implemented the Integrated “Ami Organics” implementing effective HSE Management private limited in the name
Slide 18: Business Segments
Business Segments Am AMI ORGANICS LTD. g Advanced Pharmaceutical 22)\>, & Specialty Chemicals 22/ Intermediates H » ~550 Products invoiced in last 5 years Parabens & Paraben formulations >Methyl Salicylate > Intermediates across 17+ therapeutic > Niche KSMs for cosmetics, finechem and areas agrochem
Slide 19: Strong and Long-term Relations with Diversified Customers across Geographies
Strong and Long-term Relations with Diversified Customers across Afi Geographies AMI ORGANICS LTD. » Well established long-term relations with domestic customers as well as MNCs across large and fast-growing markets 500+ ~55 Customers Countries > Diversified customer base (customer locations) » Long
Slide 20: Strong and Long-term relations with Diversified Customers across Geographies (cont'd)
Strong and Long-term relations with Diversified Customers across Geographies (cont’d) Ao AMI ORGANICS LTD. (@) Cipla ~ ~ H = #|neTerRo @ Dr.Reddy’s “:‘ AUROBINDO Midas® Pharma ORGANIKE Advanced Generic Pharma " Zydus Intermediates F1S fasorica s% é) medichem @LAURUS Labs (Top Clients) LUPIN Sintetic
Slide 21: State-of-the-Art Manufacturing Facilities
State-of-the-Art Manufacturing Facilities m&fim ’ 76,891 ‘ \ ~1,100 Total Land Area (sq mtrs) Total Installed Capacity (KL) Sachin, Gujarat Ankleshwar, Gujarat Jhagadia, Gujarat Greater Noida, UP 2, PR e Land Area Installed Capacity Land Area Installed Capacity Land Area Installed Capacity Land Area
Slide 22: R&D Centric Organization
R&D Centric Organization... AMI ORGANICS LTD. R&D Expenditure State-of-the-Art (INR mn) R&D Lab Technology Equipment ADL fully supported by analytical * Modern fume hood system fl nm 23,681 sq. ft. instruments like: * Autoclave State of art R&D facility at Sachin R&D expenditure as % * LCMASS « High
Slide 23: Superior R&D Capabilities (Cont'd)
I Superior R&D Capabilities (Cont'd) Afi AMI ORGANICS LTD. Our Capabilities in Key Chemistry IJ Etherification IJAcylatlon IJ Fluorination Nitration Esterification /J Bromination (5 ) Diazotization Hydrogenation Alkylation Amination Chlorination & hydrolysis AMI Organics R&D Centre in Surat
Slide 24: Superior R&D Capabilities (Cont'd)
Superior R&D Capabilities (Cont'd) Afl AMI ORGANICS LTD. Continuous Flow Reactor » Continuous flow reactors are more efficient, and sustainable when compared to manufacturing products using traditional reactors. » Successfully developed capabilities in Plug Flow, Catalytic fixed-bed flow, Tubular flo
Slide 25: Our Founders
Our Founders Ao AMI ORGANICS LTD. > Mr. Nareshkumar Patel is founder of the Company > He has been associated with the Company since its inception and has extensive experience in the global generic pharma business > He s responsible for handling the Chemical Engineering and Product Implementation div
Slide 26: Our Leadership
Our Leadership AMI ORGANICS 0 LTD. Board of Directors ®@ Virendra Mishra 0 Girikrishna Maniar @& Richa Goyal & Hetal Gandhi Dr. Anita Bandyopadhyay i Mr. Ram Mohan Lokhande Whole — time Non — executive, Non — executive, Non — executive Independent Whole — time Director Independent Director Independe
Slide 27: What Makes Us Different
I What Makes Us Different ? Ao AMI ORGANICS LTD. ) Niche Product Portfolio C) High Entry () P Diversified iProducts to (=) LO Diversified Customer B Reputation for Robust Cost with a Strong Market Barriers Support Future Growth Base across Innovative Product Management / Process Share Geographies La
Slide 28: 3. Advanced Pharma Intermediate
3. Advanced Pharma Intermediate » A leading Advanced Intermediate Manufacturer from India » Our Business Model » Uniqueness of our business model » Our Strategy and Outlook » Industry Overview
Slide 29: Advanced Pharmaceutical Intermediates
Advanced Pharmaceutical Intermediates Am AMI ORGANICS LTD. Historical Business Performance (INR mn) e 2678 Fy24 <= 9 17+ Therapeutic & 150+ Customers 5,678 Revenue Areas in FY24 2180 (INR mn)) 4,270 3,240 2322 I ‘ = : : g 25 + :U 1 5 - 2 FY20 FY21 FY22 FY23 FY24 Countries — Process Patents Manufactu
Slide 30: Our Business Model - Advanced Intermediates for Pharmaceuticals
Our Business Model - Advanced Intermediates for Pharmaceuticals Afl AMI ORGANICS LTD. Revenue breakup for FY24 CDMO B » Contract Manufacturing for big pharma companies ~10% NT " 8 > Exclusive long term supply contracts Regulatory market business » Supplying NCE molecules to the pharma innovator compa
Slide 31: Uniqueness of our business model
Uniqueness of our business model Ao AMI ORGANICS LTD. OOChronic Therapy focused > ~95% of the Wide Product Basket > Wider basket of R&D Leadership First to market with target products Presence across value chain > AMI is present across Preferred Supplier » Our unique business > Strong Customer Base
Slide 32: Our Strategy — Advanced Pharmaceutical Intermediates
Our Strategy — Advanced Pharmaceutical Intermediates Afl AMI ORGANICS LTD. Grow the Innovator business with more focus on COMO opportunities Commercialise products way ahead of time for drugs going off-patent in the coming years Continue to develop innovative products for the global market Ramp up pr
Slide 33: Industry Overview (1/2)
® Industry Overview (1/2) 0 AMI ORGANICS LTD. Global API Market Global Pharmaceutical Intermediates Market (USD bn) (USD bn) 51 38 37 2023 2028E ...........................................................................................................................................................
Slide 34: 4. Specialty Chemicals
4. Specialty Chemicals » Speciality Chemicals - Overview » Our Strategy and Outlook » Industry Overview
Slide 35: Speciality Chemicals
Speciality Chemicals Afl AMI ORGANICS LTD. Historical Business Performance (INR mn) 1,497 1 - 3 40+ % FY24 L Business % Products CAGR 112% Revenue Segments (INR mn) > Spedialty Chemicals for various industries e.g. Cosmetics, Finechem, Agrochem, etc. > Battery Chemicals > Semiconductor Chemicals I I
Slide 36: Our Strategy — Speciality Chemicals
Our Strategy — Speciality Chemicals AMI ORGANICS LTD. Development and entry Continue to work on into newer applications improving operational having strong entry efficiencies to deliver barriers better margins Leverage the technology Grow the Battery and capability of Baba Fine Chemicals segment - C
Slide 37: Industry Overview (2/2)
® Industry Overview (2/ AMI ORGANICS LTD. Global Specialty Chemicals Market 125%CACR (USD bn) s R 11.2 (USD bn) 6.5 16.0% CAGR 148%CAGR 34 0.8 1.6 36% CAGR 2018 /;37 2023 2028E 785 Electrolyte Additives Electrolyte Solutions a_(WoCAfiR 68.9 (USD bn) STRCAGR 515 39.0 5.5% CAGR 48%CAGR 31 1.9 23 2018 2
Slide 38: 5. Working towards better tomorrow
Ao AMI ORGANICS LTD. /4 b/ 3 | 5. Working towards better tomorrow
Slide 39: ESG Focus — Working towards a Better Tomorrow
ESG Focus — Working towards a Better Tomorrow Afl AMI ORGANICS LTD. = K Environment Social Governance » Zero Liquid Discharge based in-house » Company'’s Sachin and Jhagadia facility is » 50% of the board constitutes of effluent plant at Sachin facility SA 8000:2014 certified independent directors 86
Slide 40: Safe Harbor
Safe Harbor Afi AMI ORGANICS LTD. The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a rec
Slide 41: Contact Us
® AMI ORGANICS LTD. Contact Us For more information please contact: Ami Organics Limited mosacsie. Ekta Srivastava Company Secretary & Compliance Officer Rahul Thakur Senior Manager — Investor Relations 40 © 2020 Ami Organics Limited, All Rights Reserved.